Stay updated on APL-9 in Mild-Moderate ARDS Clinical Trial
Sign up to get notified when there's something new on the APL-9 in Mild-Moderate ARDS Clinical Trial page.

Latest updates to the APL-9 in Mild-Moderate ARDS Clinical Trial page
- Check6 days agoChange DetectedUI updates include adding Show glossary and Hide glossary options. Metadata tweaks adjust capitalization of QC criteria labels and update the revision to v3.4.0.SummaryDifference0.3%

- Check14 days agoChange DetectedThe page shows an update from Revision: v3.3.3 to Revision: v3.3.4, a minor internal version change that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check42 days agoChange DetectedThe study's Locations section was updated to add new sites in California, Florida, Illinois, Indiana, Iowa, Kentucky, Louisiana, Michigan, New Jersey, New York, and Texas, as well as locations in Paraná, Rio Grande do Sul, and São Paulo. It also removed the previous location groupings.SummaryDifference1%

- Check64 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 removed; the change updates revision metadata and does not modify core study content, eligibility, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check71 days agoChange DetectedRemoved the banner about potential operating status changes due to government funding. The page’s study details, eligibility criteria, and listed locations remain unchanged.SummaryDifference0.3%

- Check93 days agoChange DetectedThe new screenshot shows minor UI and layout updates on the Study Details page with no substantive edits to the study's design, eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to APL-9 in Mild-Moderate ARDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-9 in Mild-Moderate ARDS Clinical Trial page.